Director, Department of Molecular Neurobiology, Max Planck Institute for Experimental Medicine
Nils Brose’s research focuses on molecular mechanisms of synapse development and function in the central nervous system.
On 9 March, Nils Brose presented data from studies of proteins called neuroligins that control the formation of nerve cell junctions, or synapses. He discussed how the loss of neuroligins perturbs synapse function and what studies of neuroligins might mean for understanding and treating autism.
You can watch a complete replay of the webinar above.
Use the comments section below to submit questions we didn’t have time to discuss during the Q&A session or to pose follow-up questions for Brose.